Ofloxavis (Ofloxacin)

Ofloxacin, the active ingredient in Ofloxavis, is a fluoroquinolone antibiotic presented as a strength/form for oral use. It treats a variety of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ofloxavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxavis is a broad‑spectrum fluoroquinolone that targets bacterial pathogens in several organ systems. - Urinary tract infection: helps eradicate common uropathogens and relieve symptoms. - Respiratory tract infection: effective against typical community‑acquired strains causing bronchitis and pneumonia. - Skin and soft‑tissue infection: aids in clearing staphylococcal and streptococcal infections. - Gonorrhoea: used as a single‑dose therapy for uncomplicated Neisseria gonorrhoeae infection.

Ofloxavis may cause a range of adverse reactions, most of which are mild and resolve after treatment ends.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Abdominal pain

Serious or Rare Side Effects: - Tendon rupture or inflammation - Peripheral neuropathy - Severe skin reactions such as Stevens‑Johnson syndrome - QT interval prolongation - Clostridioides difficile‑associated colitis

When ​ ​  ​  ​  ​  ​   ​    ​    ​    ​       ​  ​         ​           ​ -       

-       t   g \,  \\